Eligibility Requirements
Covered Medications
The following medications are covered by Dupixent MyWay:
What Makes Dupixent MyWay Different
Dupixent (dupilumab) is a first-in-class IL-4/IL-13 inhibitor jointly developed by Sanofi and Regeneron. At a retail cost of ,700 or more per month ($44,000+ per year), it is one of the most expensive self-injectable biologics on the market. The drug has expanded rapidly beyond its original eczema indication and now carries FDA approvals for moderate-to-severe atopic dermatitis (ages 6 months and up), moderate-to-severe asthma with an eosinophilic phenotype, chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic esophagitis (EoE), and prurigo nodularis. This breadth of indications means millions of patients across different specialties, from dermatology to pulmonology to gastroenterology, may be eligible for assistance.
The Dupixent MyWay program operates on two tracks. For commercially insured patients, the copay card can reduce out-of-pocket costs to $0 per month with no annual cap for eligible patients. This is one of the most generous copay cards in the biologic space. For uninsured patients, Sanofi Patient Connection provides free Dupixent to households earning up to 400% of the Federal Poverty Level (approximately $60,240 for an individual). The program also provides comprehensive nursing support: a dedicated Dupixent MyWay nurse is available by phone to walk patients through injection technique, help manage side effects, and answer questions about storage and handling.
One unique aspect of Dupixent distribution is that it ships through specialty pharmacies, not your local retail pharmacy. This means you will receive medication by mail (usually via refrigerated packaging) from pharmacies like AllianceRx Walgreens, Accredo, or CVS Specialty. Your first order may take seven to ten business days after approval, so plan accordingly with your prescriber to avoid gaps in therapy. Dupixent requires refrigeration between 36 to 46 degrees Fahrenheit and should be brought to room temperature 30 to 45 minutes before injection. When renewing your PAP enrollment, start the process at least six weeks before expiration. Patients who experience insurance changes mid-year (such as losing employer coverage) should contact Dupixent MyWay at 1-844-387-4936 immediately, as they can often expedite a transition from copay card to free medication within days.
How to Apply
- Speak with your healthcare provider about Dupixent MyWay. Your doctor, nurse, or social worker can help determine if you qualify.
- Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
- Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
- Wait for approval (typically 2 to 6 weeks). Once approved, medications will be shipped to your provider's office or a designated pharmacy.
Check If You Qualify
Use our free Assistance Finder tool to check eligibility for Dupixent MyWay and other programs that may help reduce your medication costs.
Open Assistance FinderFrequently Asked Questions
Uninsured patients who meet income guidelines (up to 400% FPL) can receive free Dupixent through Sanofi Patient Connection. Apply through your dermatologist, allergist, or other prescribing physician.
The Dupixent MyWay copay card can reduce out-of-pocket costs to as low as $0 per month for commercially insured patients. The card covers Dupixent for all FDA-approved indications.
No, the Dupixent MyWay copay card is only for commercially insured patients. Medicare patients may qualify for free Dupixent through Sanofi Patient Connection if they meet income requirements.
Related Resources
- Compare pharmacy prices for Dupixent on RxGrab
- Dupixent supplement guide on Health Britannica
- Check drug interactions for Dupixent on OmniRx
- Browse all patient assistance programs
Get Prescription Savings Alerts
Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.